Gene Therapy — Predicted 2026

AI-Predicted Question Angles for UPSC 2026

Based on trend analysis, current affairs, and recurring themes in Gene Therapy.

Ethical and Regulatory Framework for Gene Editing in India

high

With the global approval of CRISPR-based gene editing therapies (Casgevy, Lyfgenia) in late 2023/early 2024, the distinction between gene therapy and gene editing, and the unique ethical dilemmas of precise genome alteration, will be a prime focus. UPSC is likely to ask about India's stance, ICMR guidelines, and the challenges of regulating such powerful tools, especially concerning germline editing and potential misuse. The question will test both scientific understanding and ethical reasoning.

Affordability and Access of Gene Therapies in India: A Policy Challenge

high

The exorbitant cost of approved gene therapies (e.g., Zolgensma) presents a significant barrier to access in a developing country like India. Questions will likely explore the socio-economic implications, the ethical imperative of equitable access, and policy measures India can adopt (indigenous R&D, public funding, innovative financing, Make in India initiatives) to make these life-saving treatments available to its population, particularly for high-burden genetic disorders like thalassemia and sickle cell anemia.

Role of Viral and Non-Viral Vectors in Gene Therapy: Advancements and Limitations

medium

Prelims often tests factual knowledge of vectors, but Mains could delve deeper into their comparative advantages, limitations, and how advancements in vector technology (e.g., safer AAVs, targeted nanoparticles) are overcoming previous hurdles. This angle would require understanding the scientific principles of delivery and their impact on therapeutic efficacy and safety, linking to recent breakthroughs and future prospects.

Gene Therapy and Cancer Treatment: A Paradigm Shift with CAR-T and Oncolytic Viruses

medium

The success of CAR-T cell therapy and the emergence of oncolytic viruses represent a significant shift in cancer treatment. UPSC could ask about the mechanisms of these therapies, their specific applications in oncology, and the challenges associated with their development and deployment (e.g., manufacturing complexity, side effects, cost). This combines biotechnology with a major public health concern.

India's Biotechnology Development Strategy and Gene Therapy: Opportunities and Roadblocks

medium

The National Biotechnology Development Strategy 2021–25 explicitly promotes advanced therapies. A Mains question could assess how this policy framework supports gene therapy R&D in India, the opportunities it creates for indigenous innovation, and the roadblocks encountered in its implementation, such as funding, infrastructure, skilled manpower, and intellectual property issues. This tests the aspirant's understanding of policy-science interface.